REXAHN PHARMACEUTICALS, INC.
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 74 Total Citation Count
- Aug 13, 2003 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0158,662 Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-Cyclopent-2-Enyl)-1H-Pyrimidin-2-OneDec 15, 16Jun 08, 17[C07D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9920016 Process for the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-oneDec 15, 16Mar 20, 18[C07F, C07D]
9744167 Nanoparticulate compositions and formulations of piperazine compoundsJun 27, 14Aug 29, 17[A61K]
9713615 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compoundsOct 21, 15Jul 25, 17[A61K, C07D]
9533958 Process or the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-Enyl)-1H-pyrimidin-2-oneSep 04, 15Jan 03, 17[C07F, C07D]
9150520 Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-oneMar 17, 14Oct 06, 15[C07F, C07D]
8598173 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumorsOct 26, 12Dec 03, 13[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0255,099 CLAVULANATE FORMULATION FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERSAbandonedApr 29, 10Oct 07, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.